Clinical Trial: A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Refractory Generalized Myasthenia Gravis

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07917923) titled 'A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Refractory Generalized Myasthenia Gravis' on Oct. 27.

Brief Summary: This is a single-arm, open-label, dose-escalating clinical trial designed to evaluate the safety, efficacy and cellular pharmacokinetics of GT802 in the treatment of refractory generalized myasthenia gravis.

Study Start Date: Dec., 2026

Study Type: INTERVENTIONAL

Condition: Generalized Myasthenia Gravis (gMG)

Intervention: BIOLOGICAL: GT802 Injection

Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Daishi Tian

Information provided by (Responsible Party): Da...